Business Description
Cardinal Health Inc
NAICS : 424210
SIC : 5122
ISIN : US14149Y1082
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.97 | |||||
Equity-to-Asset | -0.07 | |||||
Debt-to-Equity | -1.37 | |||||
Debt-to-EBITDA | 2.5 | |||||
Interest Coverage | 31.23 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 5 | |||||
Beneish M-Score | -2.76 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.5 | |||||
3-Year EPS without NRI Growth Rate | 2 | |||||
3-Year FCF Growth Rate | 18.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 14.6 | |||||
Future 3-5Y Total Revenue Growth Rate | 9 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.98 | |||||
Quick Ratio | 0.5 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 29.79 | |||||
Days Sales Outstanding | 19.19 | |||||
Days Payable | 54.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.29 | |||||
3-Year Dividend Growth Rate | 1 | |||||
3-Year Average Share Buyback Ratio | 5 | |||||
Shareholder Yield % | 10.53 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 3.34 | |||||
Operating Margin % | 0.94 | |||||
Net Margin % | 0.3 | |||||
FCF Margin % | 1.58 | |||||
ROE % | Neg. Equity | |||||
ROA % | 1.44 | |||||
ROIC % | 11.37 | |||||
ROC (Joel Greenblatt) % | 49.54 | |||||
ROCE % | 12.24 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 40.63 | |||||
Forward PE Ratio | 13.37 | |||||
PE Ratio without NRI | 15.09 | |||||
Shiller PE Ratio | 101.44 | |||||
Price-to-Owner-Earnings | 10.04 | |||||
PS Ratio | 0.12 | |||||
Price-to-Free-Cash-Flow | 7.62 | |||||
Price-to-Operating-Cash-Flow | 6.6 | |||||
EV-to-EBIT | 21.14 | |||||
EV-to-EBITDA | 13.34 | |||||
EV-to-Revenue | 0.12 | |||||
EV-to-FCF | 7.38 | |||||
Price-to-Projected-FCF | 1.09 | |||||
Price-to-Median-PS-Value | 0.99 | |||||
Earnings Yield (Greenblatt) % | 4.73 | |||||
FCF Yield % | 13.63 | |||||
Forward Rate of Return (Yacktman) % | 2.93 |